Vrielink H - Search Results

1

Confirmation of hepatitis C infection: a comparison of five immunoblot assays.

Zaaijer HL, Vrielink H, van Exel-Oehlers PJ, Cuypers HT, Lelie PN. Zaaijer HL, et al. Among authors: vrielink h. Transfusion. 1994 Jul;34(7):603-7. doi: 10.1046/j.1537-2995.1994.34794330015.x. Transfusion. 1994. PMID: 7519796

2

Editor's bio: Dr. Hans Vrielink.

Vrielink H. Vrielink H. Transfus Apher Sci. 2023 Apr;62(2):103663. doi: 10.1016/j.transci.2023.103663. Epub 2023 Feb 24. Transfus Apher Sci. 2023. PMID: 36872124 No abstract available.

3

Sensitivity and specificity of three third-generation anti-hepatitis C virus ELISAs.

Vrielink H, Zaaijer HL, Reesink HW, van der Poel CL, Cuypers HT, Lelie PN. Vrielink H, et al. Vox Sang. 1995;69(1):14-7. doi: 10.1111/j.1423-0410.1995.tb00341.x. Vox Sang. 1995. PMID: 7483486 Clinical Trial.

4

Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report.

Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Lelie PN. Vrielink H, et al. Vox Sang. 1995;68(1):55-6. doi: 10.1111/j.1423-0410.1995.tb02546.x. Vox Sang. 1995. PMID: 7536990

5

Comparison of two anti-hepatitis C virus enzyme-linked immunosorbent assays: Wellcozyme VK45 and Ortho 2.0.

Vrielink H, van der Poel CL, Reesink HW, Lelie PN. Vrielink H, et al. Infusionsther Transfusionsmed. 1995 Jun;22(3):164-7. doi: 10.1159/000223117. Infusionsther Transfusionsmed. 1995. PMID: 7543783

6

Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus.

Damen M, Zaaijer HL, Cuypers HT, Vrielink H, van der Poel CL, Reesink HW, Lelie PN. Damen M, et al. Among authors: vrielink h. Transfusion. 1995 Sep;35(9):745-9. doi: 10.1046/j.1537-2995.1995.35996029158.x. Transfusion. 1995. PMID: 7570934

7

Comparison of two anti-hepatitis C virus enzyme-linked immunosorbent assays.

Vrielink H, Zaaijer HL, Reesink HW, Lelie PN, van der Poel CL. Vrielink H, et al. Transfusion. 1995 Jul;35(7):601-4. doi: 10.1046/j.1537-2995.1995.35795357885.x. Transfusion. 1995. PMID: 7631395

8

Evaluation of a combined lysate/recombinant antigen anti-HTLV-I/II ELISA in high and low endemic areas of HTLV-I/II infection.

Vrielink H, Sisay Y, Reesink HW, Woerdeman M, Winkel C, de Leeuw SJ, Lelie PN, van der Poel CL. Vrielink H, et al. Transfus Med. 1995 Jun;5(2):135-7. doi: 10.1111/j.1365-3148.1995.tb00201.x. Transfus Med. 1995. PMID: 7655577

9

Look-back study of infectivity of anti-HCV ELISA-positive blood components.

Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Scholten E, Kremer LC, Cuypers HT, Lelie PN, van Oers MH. Vrielink H, et al. Lancet. 1995 Jan 14;345(8942):95-6. doi: 10.1016/s0140-6736(95)90063-2. Lancet. 1995. PMID: 7815889

10

New immunoblot resolves indeterminate results for antibody to hepatitis C virus.

Zaaijer HL, Cuypers HT, Reesink HW, Lelie PN, Vrielink H, van der Poel CL. Zaaijer HL, et al. Among authors: vrielink h. Transfusion. 1994 Feb;34(2):184. doi: 10.1046/j.1537-2995.1994.34294143953.x. Transfusion. 1994. PMID: 8310494 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters